Pricing

TRV GP IV, LLC

1 follower ·
BOSTON MA
13F Summary
TRV GP IV is based out of Boston. Their last reported 13F filing for Q4 2023 included $246,145,864 in managed 13F securities and a top 10 holdings concentration of 100.0%. TRV GP IV's largest holding is Tango Therapeutics Inc with shares held of 19,363,975. Whalewisdom has at least 21 13F filings, and 6 Form 4 filings

2023-12-31

Top Buys (13F)

Name % Change

2023-12-31

Top Sells (13F)

Name % Change

2023-12-31

13F Holdings Summary

Name $ Change
TNGX Tango Therapeutics I 77.88%
PLRX Pliant Therapeutics, 15.69%
FULC Fulcrum Therapeutics 6.43%

2023-12-31

13F Activity

Market Value $246m, Prior: $265m
New Purchases 0 stocks
Added To 0 stocks
Sold out of 0 stocks
Reduced holdings in 0 stocks
Top 10 Holdings % 100%
Turnover %[1] 0%
Turnover Alt %[2] 0%
Time Held Top 20 13.3333 quarters
Time Held Top 10 13.3333 quarters
Time Held All 13.33 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance